1. 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor
- Author
-
Martinez, Mariano, Batista, Fernando, Maurel, Manon, Bouillon, Anthony, Ortega Varga, Laura, Wehenkel, Anne Marie, Le Chevalier-Sontag, Lucile, Blondel, Arnaud, Haouz, Ahmed, Hernandez, Jean-François, Alzari, Pedro, Barale, Jean-Christophe, Microbiologie structurale - Structural Microbiology (Microb. Struc. (UMR_3528 / U-Pasteur_5)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Institut des Biomolécules Max Mousseron [Pôle Chimie Balard] (IBMM), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Université de Montpellier (UM), Bioinformatique structurale - Structural Bioinformatics, Cristallographie (Plateforme) - Crystallography (Platform), ANR, CNRS et Institut Pasteur, For this work, A. Bouillon and M. Martinez were supported by Agence Nationale pour la Recherche (ANR) grant ANR-11-RPIB-002 and FB and LO were supported by grant ANR-19-CE18-0010. LO was also supported by ANR-17-CE11-0030 and by the ‘URGENCE COVID-19’ fundraising campaign of Institut Pasteur. Part of this work and M. Maurel were supported by Carnot Chimie Balard Institute through ANR program 11 CARN 0001-01., ANR-11-RPIB-0002,MaPI,Développement d'un composé 'leader' à l'origine d'une nouvelle génération d'anti-paludiques: une approche multi-cibles(2011), ANR-19-CE18-0010,SPIM,Synthèse, biologie et structure pour guider l'optimisation d'Inhibiteurs de la peptidase SUB1 de Plasmodium, une cible potentielle pour le traitement du paludisme(2019), and ANR-17-CE11-0030,NICOFIVE,Découverte de modulateurs allostériques ciblant les récepteurs nicotiniques alpha5(2017)
- Subjects
Plasmodium ,malaria ,[CHIM.CRIS]Chemical Sciences/Cristallography ,therapeutic target ,subtilisin ,[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology ,[CHIM.THER]Chemical Sciences/Medicinal Chemistry ,crystalography - Abstract
International audience; The constant selection and propagation of multi-resistant Plasmodium sp. parasites require the identification of new antimalarial candidates involved in as-yet untargeted metabolic pathways. Subtilisin-like protease 1 (SUB1) belongs to a new generation of drug targets because it plays a crucial role during egress of the parasite from infected host cells at different stages of its life cycle. SUB1 is characterized by an unusual pro-region that tightly interacts with its cognate catalytic domain, thus precluding 3D structural analysis of enzyme–inhibitor complexes. In the present study, to overcome this limitation, stringent ionic conditions and controlled proteolysis of recombinant full-length P. vivax SUB1 were used to obtain crystals of an active and stable catalytic domain (PvS1 Cat ) without a pro-region. High-resolution 3D structures of PvS1 Cat , alone and in complex with an α-ketoamide substrate-derived inhibitor (MAM-117), showed that, as expected, the catalytic serine of SUB1 formed a covalent bond with the α-keto group of the inhibitor. A network of hydrogen bonds and hydrophobic interactions stabilized the complex, including at the P1′ and P2′ positions of the inhibitor, although P′ residues are usually less important in defining the substrate specificity of subtilisins. Moreover, when associated with a substrate-derived peptidomimetic inhibitor, the catalytic groove of SUB1 underwent significant structural changes, particularly in its S4 pocket. These findings pave the way for future strategies for the design of optimized SUB1-specific inhibitors that may define a novel class of antimalarial candidates.
- Published
- 2023
- Full Text
- View/download PDF